GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » ROE % Adjusted to Book Value

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) ROE % Adjusted to Book Value : -14.50% (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Staidson (Beijing) Biopharmaceuticals Co ROE % Adjusted to Book Value?

Staidson (Beijing) Biopharmaceuticals Co's ROE % for the quarter that ended in Dec. 2024 was -55.24%. Staidson (Beijing) Biopharmaceuticals Co's PB Ratio for the quarter that ended in Dec. 2024 was 3.81. Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -14.50%.

Staidson (Beijing) Biopharmaceuticals Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staidson (Beijing) Biopharmaceuticals Co ROE % Adjusted to Book Value Chart

Staidson (Beijing) Biopharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.05 -1.63 -2.84 -7.06 -3.90

Staidson (Beijing) Biopharmaceuticals Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.35 -0.47 0.05 -0.62 -14.50

Competitive Comparison of Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value falls into.


';

Staidson (Beijing) Biopharmaceuticals Co ROE % Adjusted to Book Value Calculation

Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-14.86% / 3.81
=-3.90%

Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-55.24% / 3.81
=-14.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staidson (Beijing) Biopharmaceuticals Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Staidson (Beijing) Biopharmaceuticals Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Staidson (Beijing) Biopharmaceuticals Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
SZSE:300381 SHSE:688238 SHSE:688767 BJSE:430047 SZSE:300942 SHSE:688399 SHSE:603590 SZSE:003020 SZSE:300149 SHSE:688302 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Website
http://www.staidson.com
Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.
Executives
Zhang Hong Shan Supervisors
Zheng Hong Supervisors
Cheng Jiang Hong Executives
Feng Yu Jing Executives
Ma Li Na Secretary, Director
Zhou Zhi Wen Director
Wang Huan Securities Affairs Representative
Zhang Rong Qin Executives
Xu Jiang Ping Executives
Cao Hai Yan Supervisors
Sun Yan Fang Executives
Jiang Li Xin Director
Gu Jian Ping Director
Xu Xiang Qing Supervisors
Gu Zhen Qi Director

Staidson (Beijing) Biopharmaceuticals Co Headlines

No Headlines